Author:
Greco R,Musto B,Arienzo V,Alborino A,Garofalo S,Marsico F
Abstract
The treatment of paroxysmal supraventricular tachycardia (PSVT) in infancy with digitalis, adenosine triphosphate (ATP) and verapamil is reported. Treatment was successful in about 90% of the patients treated with ATP and verapamil and in 61--71% of the patients treated with digitalis (Lanatoside C). Verapamil terminated the tachycardia within 2 minutes of administration in most instances and ATP in less than 1 minute. Digitalis, however, took as long as 2 hours; it was therefore excluded as the drug of first choice in emergencies, and is better suited for treating patients with poor hemodynamics. Side effects with ATP are common but short-lived. With verapamil, side effects are rare, but may be serious if certain contraindications are not taken into account. Digitalis in the dose used in this trial rarely produced side effects. We conclude that ATP or verapamil is the drug of first choice for quick termination of PSVT in infancy.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference34 articles.
1. I. Moss AJ Adams FH Emmanouilides GC: Heart Disease in Infants Children and Adolescents 2nd ed. Baltimore Williams & Wilkins 1977 p 691
2. Nadas AS Fyler DC: Pediatric Cardiology. Philadelphia WB Saunders 1972 p 196
3. ADENOSINE TRIPHOSPHATE IN PAROXYSMAL TACHYCARDIA
4. ADENOSINE TRIPHOSPHATE IN PAROXYSMAL TACHYCARDIA
5. L'utilisation de l'adenosine-5- triphosphorique dans le diagnostic et le traitment des tachycardies paroxystiques;Latour H;Soc Franc Cardiol,1967
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献